Fibroblast Activation Protein Expressing Mesenchymal Cells Promote Glioblastoma Angiogenesis
Authors:
- Eva BalaziovaEBEva Balaziova
- Petr VymolaPVPetr Vymola
- Petr HrabalPHPetr Hrabal
- Rosana MateuRMRosana Mateu
- Michal ZubalMZMichal Zubal
- Robert TomasRTRobert Tomas
- David NetukaDNDavid Netuka
- Filip KramarFKFilip Kramar
- Zuzana ZemanovaZZZuzana Zemanova
- Karla SvobodovaKSKarla Svobodova
- Marek BrabecMBMarek Brabec
- Aleksi SedoASAleksi Sedo
Open Access
Abstract
Fibroblast activation protein (FAP) is a membrane-bound protease that is upregulated in a wide range of tumours and viewed as a marker of tumour-promoting stroma. Previously, we demonstrated increased FAP expression in glioblastomas and described its localisation in cancer and stromal cells. In this study, we show that FAP+ stromal cells are mostly localised in the vicinity of activated CD105+ endothelial cells and their quantity positively correlates with glioblastoma vascularisation. FAP+ mesenchymal cells derived from human glioblastomas are non-tumorigenic and mostly lack the cytogenetic aberrations characteristic of glioblastomas. Conditioned media from these cells induce angiogenic sprouting and chemotaxis of endothelial cells and promote migration and growth of glioma cells. In a chorioallantoic membrane assay, co-application of FAP+ mesenchymal cells with glioma cells was associated with enhanced abnormal angiogenesis, as evidenced by an increased number of erythrocytes in vessel-like structures and higher occurrence of haemorrhages. FAP+ mesenchymal cells express proangiogenic factors, but in comparison to normal pericytes exhibit decreased levels of antiangiogenic molecules and an increased Angiopoietin 2/1 ratio. Our results show that FAP+ mesenchymal cells promote angiogenesis and glioma cell migration and growth by paracrine communication and in this manner, they may thus contribute to glioblastoma progression.Keywords
Funding Information
- Ministerstvo Školství, Mládeže a Tělovýchovy (LM2018133, CZ.02.1.01/0.0/0.0/16_019/0000785)
- Grantová Agentura, Univerzita Karlova (1084120)
- Univerzita Karlova v Praze (Progres Q28/1LFUK)
- Ministerstvo Zdravotnictví Ceské Republiky (Conceptual development of research organization 64165, General University Hospital in Prague, Czech Republic, NU21-04-00100)
This publication has 71 references indexed in Scilit:
- Dying endothelial cells stimulate proliferation of malignant glioma cells via a caspase 3-mediated pathwayOncology Letters, 2013
- Recruited Cells Can Become Transformed and Overtake PDGF-Induced Murine Gliomas In Vivo during Tumor ProgressionPLOS ONE, 2011
- Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functionsClinical & Experimental Metastasis, 2011
- Expression and role of the cell surface protease seprase/fibroblast activation protein-α (FAP-α) in astroglial tumorsBiological Chemistry, 2011
- TWIST1 promotes invasion through mesenchymal change in human glioblastomaMolecular Cancer, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in miceJournal of Clinical Investigation, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Hepatitis B Virus Promotes Angiopoietin-2 Expression in Liver TissueThe American Journal of Pathology, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005